NCT05408247View on ClinicalTrials.gov

A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder

PHASE4RecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

February 16, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2026

Conditions
Alcohol Use Disorder (AUD)
Interventions
DRUG

N-acetyl cysteine

2400mg/day

DRUG

Placebo

Matched placebo

Trial Locations (3)

2050

RECRUITING

Drug Health Services, Royal Prince Alfred Hospital, Sydney

3121

ACTIVE_NOT_RECRUITING

Turning Point, Richmond

4103

NOT_YET_RECRUITING

Cornwall Street Medical Centre (UQ Health Care), Annerley

All Listed Sponsors
collaborator

Monash University

OTHER

lead

University of Sydney

OTHER